Porcine reproductive and respiratory syndrome (PRRS) continues to challenge the swine industry, both in management and profitability, but it’s not the only respiratory disease attacking producers’ bottom lines. The Respiratory Disease Research Board (formerly the PRRS Research Review Board), with financial support from Boehringer Ingelheim Vetmedica, Inc. (BIVI), is pleased to announce an expansion of the Research Award program to include additional respiratory pathogens. Three $35,000 awards will be available.
Over the last 12 years, Research Awards totaling $1 million supported development of less costly, additional diagnostic testing and sampling processes, identified more effective biosecurity practices, sought to better understand PRRS virus transmission and developed risk assessment tools, therapeutic intervention programs and vaccination strategies.
